ArticleArchives of Razi Institute2022

A Prognostic Impact of Interleukin 17 (IL-17) as an Immune-Marker in Patients with Bladder Cancer.

F A Mousa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.